ArticleNature biomedical engineering2024

Engineered allogeneic T cells decoupling T-cell-receptor and CD3 signalling enhance the antitumour activity of bispecific antibodies.

Edo Kapetanovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.